Total Payments
$1,097
2023 Payments
$610.50
Companies
17
Transactions
62
Medicare Patients
1,018
Medicare Billing
$73,560
Payment Breakdown by Category
Food & Beverage$1,097 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,097 | 62 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $210.05 | 12 | $0 (2023) |
| Lilly USA, LLC | $199.78 | 12 | $0 (2023) |
| Astellas Pharma US Inc | $156.25 | 7 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $126.12 | 8 | $0 (2023) |
| Novo Nordisk Inc | $96.45 | 6 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $50.11 | 2 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $45.64 | 1 | $0 (2018) |
| Almatica Pharma LLC | $39.03 | 2 | $0 (2022) |
| Merck Sharp & Dohme LLC | $38.51 | 3 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $27.81 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $610.50 | 34 | ABBVIE INC. ($210.05) |
| 2022 | $201.44 | 11 | Lilly USA, LLC ($69.61) |
| 2021 | $61.78 | 3 | Biohaven Pharmaceuticals, Inc. ($27.81) |
| 2020 | $17.80 | 1 | AstraZeneca Pharmaceuticals LP ($17.80) |
| 2019 | $113.56 | 8 | Merck Sharp & Dohme Corporation ($26.11) |
| 2018 | $45.64 | 1 | Kowa Pharmaceuticals America, Inc. ($45.64) |
| 2017 | $46.64 | 4 | Allergan Inc. ($14.30) |
All Payment Transactions
62 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: Diabetes | ||||||
| 11/14/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $19.18 | General |
| Category: Respiratory | ||||||
| 10/31/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: NEUROSCIENCE | ||||||
| 10/20/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: Diabetes | ||||||
| 10/19/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.00 | General |
| Category: Biological | ||||||
| 10/17/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: Biological | ||||||
| 09/20/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 09/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Diabetes | ||||||
| 09/08/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: NEUROSCIENCE | ||||||
| 09/06/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Biological | ||||||
| 08/24/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $28.16 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Biological | ||||||
| 08/10/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: Diabetes | ||||||
| 07/26/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: NEUROSCIENCE | ||||||
| 07/13/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $7.02 | General |
| Category: Diabetes | ||||||
| 07/12/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.21 | General |
| Category: Biological | ||||||
| 07/10/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Respiratory | ||||||
| 06/21/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/14/2023 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Diabetes | ||||||
| 06/08/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $30.25 | General |
| Category: Biological | ||||||
| 06/07/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.19 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 201 | 307 | $64,123 | $11,298 |
| 2022 | 9 | 247 | 345 | $62,779 | $14,987 |
| 2021 | 8 | 240 | 393 | $80,322 | $23,443 |
| 2020 | 11 | 330 | 538 | $75,906 | $23,831 |
Total Patients
1,018
Total Services
1,583
Medicare Billing
$73,560
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 100 | 188 | $47,564 | $7,743 | 16.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 38 | 38 | $7,524 | $1,630 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 19 | 23 | $4,094 | $743.83 | 18.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $3,822 | $542.01 | 14.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 13 | $351.00 | $343.98 | 98.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 19 | 32 | $768.00 | $295.12 | 38.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 174 | $44,022 | $7,881 | 17.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 14 | 14 | $2,478 | $1,854 | 74.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 34 | 34 | $6,732 | $1,543 | 22.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 28 | $4,984 | $1,087 | 21.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 13 | 13 | $1,391 | $913.25 | 65.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 19 | 19 | $513.00 | $504.36 | 98.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 11 | 13 | $1,417 | $484.28 | 34.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 14 | 14 | $378.00 | $375.03 | 99.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 20 | 36 | $864.00 | $345.32 | 40.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 111 | 250 | $62,111 | $14,080 | 22.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 31 | 31 | $6,138 | $3,988 | 65.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 15 | 15 | $4,410 | $2,450 | 55.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 22 | $3,866 | $968.32 | 25.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 14 | 14 | $1,092 | $909.36 | 83.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 11 | 14 | $1,526 | $490.44 | 32.1% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 20 | 30 | $720.00 | $281.59 | 39.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 17 | 17 | $459.00 | $275.11 | 59.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 132 | 297 | $55,163 | $13,564 | 24.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 15 | 15 | $4,410 | $2,536 | 57.5% |
About Rebekka Hom
Rebekka Hom is a Internal Medicine healthcare provider based in Fairlawn, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2012. The National Provider Identifier (NPI) number assigned to this provider is 1659634657.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Rebekka Hom has received a total of $1,097 in payments from pharmaceutical and medical device companies, with $610.50 received in 2023. These payments were reported across 62 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,097).
As a Medicare-enrolled provider, Hom has provided services to 1,018 Medicare beneficiaries, totaling 1,583 services with total Medicare billing of $73,560. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Fairlawn, OH
- Active Since 06/25/2012
- Last Updated 10/02/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1659634657
Products in Payments
- Veozah (Drug) $138.75
- QULIPTA (Drug) $109.52
- MOUNJARO (Drug) $105.50
- UBRELVY (Drug) $100.53
- FARXIGA (Drug) $92.41
- NURTEC ODT (Drug) $77.92
- TRULICITY (Drug) $51.43
- Livalo (Drug) $45.64
- JARDIANCE (Drug) $42.85
- BREZTRI (Drug) $33.71
- Ozempic (Drug) $32.89
- Rybelsus (Drug) $31.48
- JANUVIA (Drug) $26.11
- AIMOVIG (Biological) $23.24
- LOREEV XR (Drug) $22.09
- Wegovy (Drug) $21.55
- Myrbetriq (Drug) $17.50
- GRALISE (Drug) $16.94
- VRAYLAR (Drug) $14.30
- TRELEGY ELLIPTA (Drug) $12.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Fairlawn
Michael Gedeon, Md, MD
Internal Medicine — Payments: $14,715
Internal Medicine $14,715
Jeffrey Eckman, Md, MD
Internal Medicine — Payments: $13,887
Internal Medicine $13,887
Mr. Richard Card, D.o, D.O
Internal Medicine — Payments: $6,819
Internal Medicine $6,819
Dr. William Polley, Md, MD
Internal Medicine — Payments: $769.25
Internal Medicine $769.25
Rashmi Srivastava, M.d, M.D
Internal Medicine — Payments: $598.27
Internal Medicine $598.27
Samantha Marie Almendras, Md, MD
Internal Medicine — Payments: $478.32
Internal Medicine $478.32